Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissueSCHROEDER, J. R; SAAH, A. J; AMBINDER, R. F et al.Clinical immunology (Orlando, Fla. Print). 1999, Vol 93, Num 3, pp 239-244, issn 1521-6616Article

Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual menHOOVER, D. R; BLACK, C; JACOBSON, L. P et al.American journal of epidemiology. 1993, Vol 138, Num 4, pp 266-278, issn 0002-9262Article

Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapySKOLASKY, R. L; PHAIR, J; DETELS, R et al.AIDS research and human retroviruses. 2001, Vol 17, Num 14, pp 1311-1316, issn 0889-2229Article

Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcomaJACOBSON, L. P; JENKINS, F. J; SPRINGER, G et al.The Journal of infectious diseases. 2000, Vol 181, Num 6, pp 1940-1949, issn 0022-1899Article

Parametric models to assess tracking of categorical high-risk sexual behaviour for HIV infectionGANGE, S. J; JACOBSON, L. P; MUNOZ, A et al.Statistics in medicine. 1996, Vol 15, Num 21-22, pp 2323-2336, issn 0277-6715Conference Paper

Impact of immnosuppression on health care use by men in the multicenter AIDS cohort study (MACS)ZUCCONI, S. L; JACOBSON, L. P; SCHRAGER, L. K et al.Journal of acquired immune deficiency syndromes. 1994, Vol 7, Num 6, pp 607-616, issn 0894-9255Article

Therapy naivete in the era of potent antiretroviral therapyJACOBSON, L. P; GORE, M. E; STRATHDEE, S. A et al.Journal of clinical epidemiology. 2001, Vol 54, Num 2, pp 149-156, issn 0895-4356Article

Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Δ32 mutationDEAN, M; JACOBSON, L. P; VLAHOV, D et al.Cancer research (Baltimore). 1999, Vol 59, Num 15, pp 3561-3564, issn 0008-5472Article

Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individualsJACOBSON, L. P; YAMASHITA, T. E; DETELS, R et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1999, Vol 21, pp s34-s41, issn 1077-9450, SUP1Conference Paper

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variantWINKLER, C; MODI, W; BUCHBINDER, S et al.Science (Washington, D.C.). 1998, Vol 279, Num 5349, pp 389-393, issn 0036-8075Article

Detection of infection with human immunodeficiency virus type 1 before seroconversion: Correlation with clinical symptoms and outcomePHAIR, J. P; MARGOLICK, J. B; JACOBSON, L. P et al.The Journal of infectious diseases. 1997, Vol 175, Num 4, pp 959-962, issn 0022-1899Article

A case-control study of HIV-1-related dementia and co-infection with HHV-8POLK, S; MUNOZ, A; SACKTOR, N. C et al.Neurology. 2002, Vol 59, Num 6, pp 950-953, issn 0028-3878Article

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usageGIORGI, J. V; HULTIN, L. E; WOLINSKY, S. M et al.The Journal of infectious diseases. 1999, Vol 179, Num 4, pp 859-870, issn 0022-1899Article

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progressionSMITH, M. W; DEAN, M; BUCHBINDER, S et al.Science (Washington, D.C.). 1997, Vol 277, Num 5328, pp 959-965, issn 0036-8075Article

Estimation, testing and adjustment of transient healthy entrant effectsHOOVER, D. R; MUNOZ, A; HE, Y et al.Biometrical journal. 1996, Vol 38, Num 2, pp 241-254, issn 0323-3847Article

Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot: evidence from a cohort of homosexual menWOLINSKY, S. M; RINALDO, C. R; CHMIEL, J. S et al.Annals of internal medicine. 1989, Vol 111, Num 12, pp 961-972, issn 0003-4819Article

Detection of human Herpesvirus 8 (HHV-8) in normal prostatesMONTGOMERY, J. D; JACOBSON, L. P; DHIR, R et al.The Prostate. 2006, Vol 66, Num 12, pp 1302-1310, issn 0270-4137, 9 p.Article

Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progressionJACOBSON, L. P; LI, R; PHAIR, J et al.American journal of epidemiology. 2002, Vol 155, Num 8, pp 760-770, issn 0002-9262Article

Estimating the effect of zidovudine on Kaposi's sarcoma from observational data using a rank preserving structural failure-time modelJOFFE, M. M; HOOVER, D. R; JACOBSON, L. P et al.Statistics in medicine. 1998, Vol 17, Num 10, pp 1073-1102, issn 0277-6715Article

Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesisBOLTON, M. G; MUNOZ, A; JACOBSON, L. P et al.Cancer research (Baltimore). 1993, Vol 53, Num 15, pp 3499-3504, issn 0008-5472Article

Changes in survival after acquired immunodeficiency syndrome (AIDS) : 1984-1991JACOBSON, L. P; KIRBY, A. J; POLK, S et al.American journal of epidemiology. 1993, Vol 138, Num 11, pp 952-964, issn 0002-9262Article

Retreatment with argon laser trabeculoplasty. DiscussionRICHTER, C. U; SHINGLETON, B. J; BELLOWS, A. R et al.Ophthalmology (Rochester, MN). 1987, Vol 94, Num 9, pp 1085-1089, issn 0161-6420Conference Paper

Serum soluble CD23 level correlates with subsequent development of AIDS-related non-hodgkin's lymphomaSCHROEDER, J. R; SAAH, A. J; ARMENIAN, H. K et al.Cancer epidemiology, biomarkers & prevention. 1999, Vol 8, Num 11, pp 979-984, issn 1055-9965Article

Protective alterations in phase 1 and 2 metabolism of aflatoxin B₁ by oltipraz in Residents of Qidong, People's Republic of ChinaWANG, J.-S; XINNAN SHEN; JACOBSON, L. P et al.Journal of the National Cancer Institute. 1999, Vol 91, Num 4, pp 347-354, issn 0027-8874Article

Effect of treatment with zidovudine on subsequent incidence of Kaposi's sarcomaJOFFE, M. M; HOOVER, D. R; JACOBSON, L. P et al.Clinical infectious diseases. 1997, Vol 25, Num 5, pp 1125-1133, issn 1058-4838Article